Metropolitan Life Insurance Company (MetLife)’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,377
| Closed | -$441K | – | 2043 |
|
|
2024
Q1 | $441K | Sell |
5,377
-176
| -3% | -$14.4K | 0.02% | 496 |
|
|
2023
Q4 | $103K | Hold |
5,553
| – | – | ﹤0.01% | 1062 |
|
|
2023
Q3 | $61.5K | Buy |
5,553
+299
| +6% | +$3.31K | ﹤0.01% | 1282 |
|
|
2023
Q2 | $85.2K | Buy |
+5,254
| New | +$85.2K | ﹤0.01% | 1106 |
|
|
2022
Q2 | – | Sell |
-4,757
| Closed | -$14.3K | – | 2436 |
|
|
2022
Q1 | $14.3K | Sell |
4,757
-10,542
| -69% | -$31.6K | ﹤0.01% | 2217 |
|
|
2021
Q4 | $70.4K | Sell |
15,299
-2,780
| -15% | -$12.8K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $114K | Buy |
18,079
+8,520
| +89% | +$53.5K | ﹤0.01% | 2460 |
|
|
2021
Q2 | $57.3K | Sell |
9,559
-10,890
| -53% | -$65.2K | ﹤0.01% | 2660 |
|
|
2021
Q1 | $129K | Buy |
20,449
+11,354
| +125% | +$71.8K | ﹤0.01% | 2307 |
|
|
2020
Q4 | $51.2K | Sell |
9,095
-5,173
| -36% | -$29.1K | ﹤0.01% | 2475 |
|
|
2020
Q3 | $83K | Sell |
14,268
-7,409
| -34% | -$43.1K | ﹤0.01% | 2321 |
|
|
2020
Q2 | $156K | Sell |
21,677
-80
| -0.4% | -$577 | ﹤0.01% | 1977 |
|
|
2020
Q1 | $102K | Buy |
21,757
+1,108
| +5% | +$5.19K | ﹤0.01% | 2017 |
|
|
2019
Q4 | $166K | Sell |
20,649
-507
| -2% | -$4.07K | ﹤0.01% | 2045 |
|
|
2019
Q3 | $146K | Hold |
21,156
| – | – | ﹤0.01% | 2092 |
|
|
2019
Q2 | $176K | Buy |
21,156
+1,028
| +5% | +$8.53K | ﹤0.01% | 1975 |
|
|
2019
Q1 | $200K | Sell |
20,128
-1,794
| -8% | -$17.8K | ﹤0.01% | 1899 |
|
|
2018
Q4 | $168K | Buy |
21,922
+6,599
| +43% | +$50.5K | ﹤0.01% | 1934 |
|
|
2018
Q3 | $267K | Hold |
15,323
| – | – | ﹤0.01% | 1812 |
|
|
2018
Q2 | $145K | Buy |
+15,323
| New | +$145K | ﹤0.01% | 2131 |
|